EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

T-Cell Epitope-Based SARS-CoV-2 DNA Vaccine Encoding an Antigen Fused with Type 1 Herpes Simplex Virus Glycoprotein D (gD)

Luana Raposo de Melo Moraes Aps iD, Aléxia Adrianne Venceslau-Carvalho iD, Carla Longo de Freitas, Bruna Felício Milazzotto Maldonado Porchia, Mariângela de Oliveira Silva, Lennon Ramos Pereira iD, Natiely Silva Sales, Guilherme Formoso Pelegrin iD, Ethiane Segabinazi iD, Karine Bitencourt Rodrigues, Jamile Ramos da Silva, Bianca da Silva Almeida und 5 weitere

Viruses · 2025

DOI: 10.3390/v17091191 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2025. Verfasst von Luana Raposo de Melo Moraes Aps und 16 weiteren Autor:innen. Beteiligte Einrichtung: Vaccine Development Laboratory, Microbiology Department, Biomedical Sciences Institute, University of São Paulo, São Paulo 05508-000, Brazil. Hauptthemen laut MEDLINE: Vaccines, DNA, Epitopes, T-Lymphocyte, Viral Envelope Proteins, SARS-CoV-2. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Amparo à Pesquisa do Estado de São Paulo, National Council for Scientific and Technological Development, Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Authorized SARS-CoV-2 vaccines elicit both antibody and T-cell responses; however, benchmark correlates and update decisions have largely emphasized neutralizing antibodies. Motivated by the complementary role of cellular immunity, we designed a prototype polyepitope DNA vaccine encoding conserved human and mouse T-cell epitopes from non-structural proteins of the original strain SARS-CoV-2 lineage. Epitope selection was guided by in silico predictions for common HLA class I alleles in the Brazilian population and the mouse H-2Kb haplotype. To enhance immunogenicity, the polyepitope sequences were fused to glycoprotein D (gD) from Herpes Simplex Virus 1 (HSV-1), an immune activator of dendritic cells (DCs), leading to enhanced activation of antigen-specific T-cell responses. Mice were immunized with two doses of the electroporated DNA vaccine encoding the gD-fused polyepitope, which induced robust interferon-gamma– and tumor necrosis factor-alpha–producing T cell responses compared to control mice. In addition, K18-hACE2 transgenic mice showed protection against intranasal challenge with the original SARS-CoV-2 strain, with reduced clinical symptoms, less weight loss, and decreased viral burden in both lung and brain tissues. The results experimentally confirm the protective role of T cells in vaccine-induced protection against SARS-CoV-2 and open perspectives for the development of universal anti-coronavirus vaccines.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vaccines, DNAEpitopes, T-LymphocyteViral Envelope ProteinsSARS-CoV-2COVID-19 VaccinesCOVID-19AnimalsMiceHumansFemaleMice, TransgenicAntibodies, ViralHerpesvirus 1, HumanAntibodies, NeutralizingAngiotensin-Converting Enzyme 2T-LymphocytesAntigens, Viral

Stichwörter der Autor:innen

K18-hACE2 mouse modelSARS-CoV-2glycoprotein D (HSV-1)polyepitope DNA vaccine

Substanzen

Vaccines, DNAEpitopes, T-LymphocyteViral Envelope ProteinsCOVID-19 Vaccinesglycoprotein D, Human herpesvirus 1Antibodies, ViralAntibodies, Neutralizingglycoprotein gD, herpes simplex virus type 1Angiotensin-Converting Enzyme 2Antigens, Viral

Autor:innen und Institutionen

  • Vaccine Development Laboratory, Microbiology Department, Biomedical Sciences Institute, University of São Paulo, São Paulo 05508-000, Brazil.
  • ImunoTera Soluções Terapêuticas Ltd.a., São Paulo 01452-922, Brazil.
  • Institut Pasteur de São Paulo, São Paulo 05508-020, Brazil.

ORCID-Profile: Luana Raposo de Melo Moraes Aps, Aléxia Adrianne Venceslau-Carvalho, Lennon Ramos Pereira, Guilherme Formoso Pelegrin, Ethiane Segabinazi, Maria Fernanda Castro-Amarante, Luís Carlos de Souza Ferreira

Förderung

  • Fundação de Amparo à Pesquisa do Estado de São Paulo
  • National Council for Scientific and Technological Development
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

Zitieren

APA

Aps, L. R. M. M., Venceslau-Carvalho, A. A., Freitas, C. L., Porchia, B. F. M. M., Silva, M. O., Pereira, L. R., Sales, N. S., Pelegrin, G. F., Segabinazi, E., Rodrigues, K. B., Silva, J. R. D., Almeida, B. D. S., Farias, J. P., Castro-Amarante, M. F., Minoprio, P. M. C., Ferreira, L. C. S., & Dos Santos Alves, R. P. (2025). T-Cell Epitope-Based SARS-CoV-2 DNA Vaccine Encoding an Antigen Fused with Type 1 Herpes Simplex Virus Glycoprotein D (gD). Viruses. https://doi.org/10.3390/v17091191

Vancouver

Aps LRMM, Venceslau-Carvalho AA, Freitas CL, Porchia BFMM, Silva MO, Pereira LR, et al. T-Cell Epitope-Based SARS-CoV-2 DNA Vaccine Encoding an Antigen Fused with Type 1 Herpes Simplex Virus Glycoprotein D (gD). Viruses. 2025. doi:10.3390/v17091191

BibTeX
@article{Aps2025,
  author = {Aps, Luana Raposo de Melo Moraes and Venceslau-Carvalho, Aléxia Adrianne and Freitas, Carla Longo de and Porchia, Bruna Felício Milazzotto Maldonado and Silva, Mariângela de Oliveira and Pereira, Lennon Ramos and Sales, Natiely Silva and Pelegrin, Guilherme Formoso and Segabinazi, Ethiane and Rodrigues, Karine Bitencourt and Silva, Jamile Ramos da and Almeida, Bianca da Silva and Farias, Jéssica Pires and Castro-Amarante, Maria Fernanda and Minoprio, Paola Marcella Camargo and Ferreira, Luís Carlos de Souza and Dos Santos Alves, Rúbens Prince},
  title = {T-Cell Epitope-Based SARS-CoV-2 DNA Vaccine Encoding an Antigen Fused with Type 1 Herpes Simplex Virus Glycoprotein D (gD)},
  journal = {Viruses},
  year = {2025},
  doi = {10.3390/v17091191}
}
Kostenlos starten →